Moleculin Biotech Inc.

1.17
-0.12 (-9.30%)
At close: Mar 03, 2025, 3:59 PM
1.13
-3.42%
Pre-market: Mar 04, 2025, 07:18 AM EST

Moleculin Biotech Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 127K 222K 260K 285K 185K 68K 18K 6.16K n/a
Gross Profit -127K -222K -260K -285K -185K -68K -18K -6.16K n/a
Operating Income -29.63M -30.64M -22.97M -19.74M -17.52M -15.03M -8.65M -3.88M -738.23K
Interest Income 1.37M 240K 306K 13K 13K n/a n/a n/a 24.32K
Pretax Income -29.77M -29.02M -15.89M -17.36M -13.43M -11.88M -9.8M -3.93M -748.36K
Net Income -29.77M -27.41M -8.86M -15M -13.21M -11.88M -9.8M -3.93M -748.36K
Selling & General & Admin 10.02M 11.67M 8.39M 6.79M 6.31M 5.3M 4.09M 2.38M 477.81K
Research & Development 19.49M 18.97M 14.42M 12.76M 11.01M 9.73M 4.54M 1.5M 260.42K
Other Expenses 127K 40K 164K 200K 199K -40K 18K 6.16K n/a
Operating Expenses 29.63M 30.64M 22.97M 19.74M 17.52M 15.03M 8.65M 3.88M 738.23K
Interest Expense n/a n/a n/a n/a n/a n/a n/a 43.21K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a -668.93K
Cost & Expenses 29.63M 30.64M 22.97M 19.74M 17.52M 15.03M 8.65M 3.88M 738.23K
Income Tax n/a -1.61M -7.03M -2.36M -229K 3.15M 1.15M n/a -1.77M
Shares Outstanding (Basic) 1.98M 1.91M 1.79M 656.38K 452.46K 287.82K 206.32K 109.19K 63K
Shares Outstanding (Diluted) 1.98M 1.91M 1.79M 656.38K 452.46K 287.82K 206.32K 109.19K 63.24K
EPS (Basic) -15.07 -14.37 -4.94 -22.85 -29.18 -41.26 -47.52 -35.96 -11.88
EPS (Diluted) -15.07 -14.37 -4.94 -22.85 -29.18 -41.26 -47.52 -35.96 -11.83
EBITDA -29.5M -30.51M -22.8M -19.54M -13.25M -14.96M -8.63M -3.88M n/a
Depreciation & Amortization 127K 222K 260K 285K 185K 68K 18K 6.16K 1.77M